Tyler Luu

Dr. Luu completed his BS degree at UCLA where he majored in molecular biology and microbiology. He went on to obtain his MD degree at the University of California, Riverside. While in medical school, Dr. Luu developed a passion for infectious diseases. He was involved in many patient safety and antibiotic restriction committees prior to coming to Yale. His research interests remained focus on antibiotic stewardship, hospital epidemiology and public health.

Publications:

Luu T, Fan A, Shaw R, Dalal H, Adams J, Santarossa M, Reid G, Tsai S, Clark NM, Albarillo S. Improved Clinical Outcomes with Appropriate Meropenem De-escalation in Patients with Febrile Neutropenia. Journal of Global Infectious Diseases 16(4):p 145-151, Oct–Dec 2024.

Shaw R, Haque AR, Luu T, et al. Multicenter analysis of immunosuppressive medications on the risk of malignancy following adult solid organ transplantation. Front Oncol. 2023;13:1146002. Published 2023 Jun 16. doi:10.3389/fonc.2023.1146002

Luu T, Khalid R, Rehman T, Clark NM. Disseminated Nocardia paucivorans Infection Resembling Metastatic Disease in a Kidney Transplant Recipient. Cureus. 2022;14(5):e25365. Published 2022 May 26. doi:10.7759/cureus.25365

Luu T, Albarillo FS. Asymptomatic Bacteriuria: Prevalence, Diagnosis, Management and Current Antimicrobial Stewardship Implementations [published online ahead of print, 2022 Mar 31]. Am J Med. 2022;S0002- 9343(22)00248-0. doi:10.1016/j.amjmed.2022.03.015

Luu T, Reid G, Lavery B. Escherichia coli associated hematogenous sternoclavicular joint osteomyelitis: A rare condition with a rare causative pathogen. IDCases. 2022;27:e01381. Published 2022 Jan 6. doi:10.1016/j.idcr.2022.e01381